Neoplastic pericardial effusion

Clinical Cardiology

Volumn 34, Issue 10, 2011, Pages 593-598

  Refaat, Marwan M ^a   Katz, William E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; MITOMYCIN C; RADIOISOTOPE; TENIPOSIDE; TETRACYCLINE; THIOTEPA;

AUTOPSY; BREAST CARCINOMA; CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; CONSTRICTIVE PERICARDITIS; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; ESOPHAGUS CARCINOMA; FIBROSARCOMA; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HEMANGIOMA; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; LEUKEMIA; LIPOMA; LUNG CARCINOMA; LYMPHANGIOMA; LYMPHATIC DRAINAGE; LYMPHOMA; MALIGNANT MESOTHELIOMA; MELANOMA; METASTASIS; MYOCARDITIS; NEOPLASTIC PERICARDIAL EFFUSION; NEUROFIBROMA; NUCLEAR MAGNETIC RESONANCE; OPPORTUNISTIC INFECTION; PATHOPHYSIOLOGY; PERICARDIAL BIOPSY; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDIOTOMY; PERICARDITIS; POLYMERASE CHAIN REACTION; PROGNOSIS; REVIEW; SHOCK; TERATOMA; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

HEMODYNAMICS; HUMANS; NEOPLASMS; PERICARDIAL EFFUSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS;

EID: 80054123447     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20936     Document Type: Review

References (45)

1. Gornik HL, Gerhard-Herman M, Beckman JA., Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol. 2005; 23: 521-526.
2. Wilkes JD, Fidias P, Vaickus L, et al. Malignancy-related pericardial effusion. Cancer. 1995; 76: 1377-1387.
3. Posner MR, Cohen GI, Skarin AT., Pericardial disease in patients with cancer: the differentiation of malignant from idiopathic and radiation-induced pericarditis. Am J Med. 1981; 71: 407-413. (Pubitemid 11054410)
4. DeCamp MM Jr, Mentzer SJ, Swanson SJ, et al. Malignant effusive disease of the pleura and pericardium. Chest. 1997; 112 (4 suppl): 291S-295S. (Pubitemid 27441098)
5. Millaire A, Wurtz A, de Groote P, et al. Malignant pericardial effusions: usefulness of pericardioscopy. Am Heart J. 1992; 124: 1030-1034.
6. Porte HL, Janecki-Delebecq TJ, Finzi L, et al. Pericardioscopy for primary management of pericardial effusion in cancer patients. Eur J Cardiothorac Surg. 1999; 16: 287-291. (Pubitemid 29443963)
7. Buck M, Ingle JN, Guilani ER, et al. Pericardial effusion in women with breast cancer. Cancer. 1987; 60: 263-271.
8. Hanfling SM., Metastatic cancer to the heart: review of the literature and report of 127 cases. Circulation. 1960; 22: 474-483.
9. Adebisi D, Adenle AD, Edwards JF., Clinical and pathologic features of metastatic neoplasms of the pericardium. Chest. 1982: 81: 166-169. (Pubitemid 12165547)
10. Hancock EW., Neoplastic pericardial disease. Cardiol Clin. 1990; 8: 673-682. (Pubitemid 20357220)
11. Katz WE, Ferson PF, Lee RF, et al. Images in cardiovascular medicine: metastatic malignant melanoma to the heart. Circulation. 1996; 93: 1066. (Pubitemid 26074842)
12. Maisch B, SeferoviÄ PM, RistiÄ AD, et al. Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases: executive summary. Eur Heart J. 2004; 25: 587-610.
13. Levitan Z, Kaplan AL, Gordon A., Survival after malignant pericardial effusion and cardiac tamponade in advanced ovarian cancer. South Med J. 1990: 83: 241-242. (Pubitemid 20081734)
14. LeWinter MM, Tischler MD., Pericardial diseases. In:, Bonow RO, Mann DL, Zipes DP, et al, eds. Braunwald's Heart Disease. 9th ed. Philadelphia, PA: Saunders; 2011: 1651-1670.
15. Galve E, Permanyer-Miralda G, Tornos MP, et al. Self limited acute pericarditis as initial manifestation of primary cardiac tumor. Am Heart J. 1992; 123: 1690-1692.
16. Soler-Soler J, Permanyer-Miralda G, SagristÇ-Sauleda J., A systematic diagnostic approach to primary acute pericardial disease: the Barcelona experience. Cardiol Clin. 1990; 8: 609-620. (Pubitemid 20357214)
17. Theologides H., Neoplastic cardiac tamponade. Semin Oncol. 1978; 5: 181-190.
18. Jneid H, Maree AO, Palacios I., Pericardial tamponade: clinical presentation, diagnosis and catheter-based therapies. In:, Parrillo JE, Dellinger RP, eds. Critical Care Medicine: Principles of Diagnosis & Management in the Adult. 3rd ed. Philadelphia, PA: Mosby; 2007.
19. Metcalfe J, Woodbury JW, Richards V, et al. Studies in experimental pericardial tamponade. Circulation. 1952; 5: 518-524.
20. Morgan BC, Guntheroth WG, Dillard DH., Relationship of pericardial to pleural pressure during quiet respiration and cardiac tamponade. Circ Res. 1965; 16: 493-498.
21. Fowler NO., Physiology of cardiac tamponade and pulsus paradoxus. II: physiological, circulatory, and pharmacological responses in cardiac tamponade. Mod Concepts Cardiovasc Dis. 1978; 47: 115-118.
22. Millard RW, Fowler NO, Gabel M., Hemodynamic and regional blood flow distribution responses to dextran, hydralazine, isoproterenol, and amrinone during experimental cardiac tamponade. J Am Coll Cardiol. 1983; 1: 461-470.
23. Beck CS., Two cardiac compression triads. JAMA. 1935; 104: 714-716.
24. Guberman BA, Fowler NO, Engel PJ, et al. Cardiac tamponade in medical patients. Circulation. 1981; 64: 633-640. (Pubitemid 11061635)
25. Reddy PS, Curtiss EI, O'Toole JD, et al. Cardiac tamponade: hemodynamic observations in man. Circulation. 1978; 58: 265-272. (Pubitemid 8395931)
26. Reddy PS, Curtiss EI., Cardiac tamponade. Cardiol Clin. 1990; 8: 627-637. (Pubitemid 20357216)
27. Curtiss EI, Reddy PS, Uretsky BF, et al. Pulsus paradoxus: definition and relation to the severity of cardiac tamponade. Am Heart J. 1988; 115: 391-398. (Pubitemid 18043286)
28. D'Cruz I, Rehman AU, Hancock HL., Quantitative echocardiographic assessment in pericardial disease. Echocardiography. 1997; 14: 207-214.
29. Mercé J, SagristÇ-Sauleda J, Permanyer-Miralda G, et al. Correlation between clinical and Doppler echocardiographic findings in patients with moderate and large pericardial effusion: implications for the diagnosis of cardiac tamponade. Am Heart J. 1999; 138: 759-764. (Pubitemid 29471053)
30. Chong HH, Plotnick GD., Pericardial effusion and tamponade: evaluation, imaging modalities, and management. Compr Ther. 1995; 21: 378-385.
31. Ha JW, Ommen SR, Tajik J, et al. Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography. Am J Cardiol. 2004; 94: 316-319. (Pubitemid 38962696)
32. Nunziata A, Catalano O, Cusati B, et al. for European Society of Radiology. Two signs of hemodynamic disturbance: contrast material reflux within the azygos vein (AV) and within the inferior vena cava (IVC) [abstract]. Presented at: Proceedings of the European Congress of Radiology; March 5-10, 2000; Vienna, Austria. Presentation 15-028.
33. Harries SR, Fox BM, Roobottom CA., Azygos reflux: a CT sign of cardiac tamponade. Clin Radiol. 1998; 53: 702-704. (Pubitemid 28431981)
34. Mulvagh SL, Rokey R, Vick GW III, et al. Usefulness of nuclear magnetic resonance imaging for evaluation of pericardial effusions, and comparison with two-dimensional echocardiography. Am J Cardiol. 1989; 64: 1002-1009. (Pubitemid 19266129)
35. Talreja DR, Nishimura RA, Oh JK, et al. Constrictive pericarditis in the modern era: novel criteria for diagnosis in the cardiac catheterization laboratory. J Am Coll Cardiol. 2008; 51: 315-319.
36. Soler-Soler J, SagristÇ-Sauleda J, Permanyer-Miralda G., Management of pericardial effusion. Heart. 2001; 86: 235-240. (Pubitemid 32983502)
37. Tsang TS, Enriquez-Sarano M, Freeman WK, et al. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc. 2002; 77: 429-436. (Pubitemid 34465150)
38. Meyers DG, Meyers RE, Prendergast TW., The usefulness of diagnostic tests on pericardial fluid. Chest. 1997; 111: 1213-1221.
39. Celermajer D, Boyer M, Bailey B, et al. Pericardiocentesis of symptomatic malignant pericardial effusion: a study of 36 patients. Med J Aust. 1991; 154: 19-22.
40. Jneid H, Ziskind A, Palacios IF., Pericardial interventions. In:, Topol EJ, Teirstein, eds. Textbook of Interventional Cardiology. 6th ed. Philadelphia, PA: Saunders; 2011, In press.
41. Hazelrigg SR, Mack MJ, Landreneau RJ, et al. Thoracoscopic pericardiectomy for effusive pericardial disease. Ann Thorac Surg. 1993; 56: 792-795. (Pubitemid 23294494)
42. Piehler JM, Pluth JR, Schaff HV, et al. Surgical management of effusive pericardial disease: influence of extent of pericardial resection on clinical course. J Thorac Cardiovasc Surg. 1985; 90: 506-516. (Pubitemid 16238042)
43. Olson JE, Ryan MB, Blumenstock DA., Eleven years experience with pericardial-peritoneal window in the management of malignant and benign pericardial effusions. Ann Surg Oncol. 1995; 2: 165-169.
44. Maher EA, Shepherd FA, Todd TJ., Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. J Thorac Cardiovasc Surg. 1996; 112: 637-643. (Pubitemid 26347017)
45. Martinoni A, Cipolla CM, Cardinale D, et al. Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa. Chest. 2004; 126: 1412-1416. (Pubitemid 39525010)